Impact of glycemic control by artificial pancreas on perioperative management such as surgical site infection: single center, prospective cohort observational study

Impact of glycemic control by artificial pancreas on perioperative management such as surgical site infection: single center, prospective cohort observational study - Impact of glycemic control by artificial pancreas on perioperative management

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041558

Enrollment

200

Registered

2020-08-26

Start date

2020-08-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who were received surgical operation including esophagectomy, hepatectomy and pancreatectomy, with artificial pancreas management

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing elective esophagectomy, hepatectomy and pancreatectomy. 2) Patients aged over 18. 3) Patients using artificial pancreas.

Exclusion criteria

Exclusion criteria: 1) Patients who require emergency surgery 2) Patients who were judged to be inappropriate as subjects by the study investigators.

Design outcomes

Primary

Measure	Time frame
To evaluate incidence of SSI and length of hospital stay and other postoperative complications.	—

Secondary

Measure	Time frame
Incidence of cardiac events, reoperation, delirium, and other complications.	—

Countries

Japan

Contacts

Public ContactYoshihito Fujita

Aichi Medical University Anesthesiology and general intensive care unit

fujita.yoshihito.823@mail.aichi-med-u.ac.jp0561623311

Outcome results